Current indications for cardiac MR imaging;Indications cliniques appropriées de l'IRM en pathologie cardio-vasculaire

Journal de Radiologie

Volumn 90, Issue 9 C2, 2009, Pages 1144-1160

  Crochet, D ^a   Helft, G ^b   Chassaing, S ^c   Revel, D ^d   Furber, A ^e  

^a CHU de Nantes   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Clinique Saint Gratien   (France)

^d LOUIS PRADEL HOSPITAL   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cardiac MRI; Clinical indications

Indexed keywords

ACUTE CORONARY SYNDROME; AORTA ANEURYSM; AORTA DISSECTION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGENITAL BLOOD VESSEL MALFORMATION; ECHOCARDIOGRAPHY; HEART VALVE STENOSIS; HEART VENTRICLE FUNCTION; HUMAN; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS; PROGNOSIS; REVIEW; TRICUSPID VALVE REGURGITATION;

EID: 74049087944     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(09)73261-5     Document Type: Article

References (193)

1. Pennell DJ, Sechtem UP, Higgins CB et al. Clinical indications for cardiovascular magnetic resonance: consensus panel report. Eur Heart J 2004;25:1940-65.
2. ACCF / ACR / SCCT / SCMR / ASNC / NASCI / SCAI / SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J Am Coll Cardiol 2006;48:1475-97.
3. ACCF / AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. J Am Coll Cardiol 2005;46:383-402.
4. Pohost GM, Kim RJ, Kramer CM, Manning WJ. Task force 12: Training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]). J Am Coll Cardiol 2006;47:910-4.
5. Furber A, Balzer P, Cavaro-ménard C et al. Experimental validation of an automated edge detection method for a simultaneous determination of the endocardial and epicardial borders in short-axis cardiac MR images. Application in normal volunteers. JMRI 1998;8:1006-14.
6. Longmore DB, Klipstein RH, Underwood SR et al. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet 1985;1:1360-2.
7. Sechtem U, Pflugfelder PW, Gould RG et al. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987;163:697-702.
8. Helbing WA, Rebergen SA, Maliepaard C et al. Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease. Am Heart J 1995;130:828-37.
9. Lethimonnier F, Furber A, Balzer P et al. Global left ventricular cardiac function: comparison between magnetic resonance imaging, radionuclide angiography, and contrast angiography. Invest Radiol 1999;34:199-203.
10. Bellenger NG, Burgess M, Ray SG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by two dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur Heart J 2000;21:1387-96.
11. Semelka RC, Tomei E, Wagner S et al. Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging. Radiology 1990;174:763-8.
12. Semelka RC, Tomei E, Wagner S et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990;119:1367-73.
13. Spuentrup E, Schroeder J, Mahnken AH et al. Quantitative assessment of left ventricular function with interactive real-time spiral and radial MR imaging. Radiology 2003;227:870-6.
14. Grothues F, Moon JC, Bellenger NG et al. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-23.
15. Beygui F, Furber A, Delepine S et al. Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study. Int J Cardiovasc Imaging 2004;20:509-16.
16. Beygui F, Furber A, Delepine S, Prunier et al. Assessment of biventricular remodeling by magnetic resonance imaging after successful primary stenting for acute myocardial infarction. Am J Cardiol 2004;94:354-7.
17. Bottini PB, Carr AA, Prisant M et al. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995;8:221-8.
18. Schalla S, Nagel E, Lehmkuhl H et al. Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 2001;87:95-9
19. Peschok RM, Rokey R, Malloy GM et al. Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. J Am Coll Cardiol 1989;14:653-9.
20. Suzuki J, Caputo GR, Masui T et al. Assessment of right ventricular diastolic and systolic function in patients with dilated cardiomyopathy using cine magnetic resonance imaging. Am Heart J 1991;122:1035-40.
21. Balzer P, Furber A, Delepine S et al. Regional assessment of wall curvature and wall stress in the left ventricle of normal subjects with magnetic resonance imaging. Am J Physiol 1999;277:H901-H910.
22. Zerhouni EA, Parish DM, Rogers WJ, Yang A, Shapiro EP. Human heart tagging with MR imaging. A method for noninvasive assessment of myocardial motion. Radiology 1988;169:59-63.
23. Garot J, Bluemke DA, Osman NF et al. Fast determination of regional myocardial strain fields from tagged cardiac images using Harmonic Phase (HARP) magnetic resonance imaging. Circulation 2000;101:981-8.
24. Hartiala JJ, Mostbeck GH, Foster E et al. Velocity-encoded cine MRI in the evaluation of left ventricular diastolic function: measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am Heart J 1993;125:1054-66.
25. Nagel E, Lorenz C, Baer F et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001;3:267-81.
26. Nagel E, Lehmkuhl, Bocksch W et al. Noninvasive diagnosis of -ischemia induced wall motion abnormalities with the use of high dose dobutamine stress MRI. Comparison with dobutamine stress echocardiography. Circulation 1999;99:763-70.
27. Hundley WG, Hamilton CA, Thomas MS et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999;100:1697-702.
28. Hundley WG, Morgan TM, Neagle CM et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002;106:2328-33.
29. Al-Saadi N, Nagel E, Gross M et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-83.
30. Schwitter J, Nanz D, Kneifel S et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
31. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenosis. N Engl J Med 2001;345:1863-9.
32. Hundley WG, Hamilton CA et al. Visualisation and functional assessment of proximal and middle left anterior descending coronary stenosis in humans with magnetic resonance imaging. Circulation 1999;99:3248-54.
33. Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23.
34. Wagner A, Mahrholdt H, Holly TA et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
35. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
36. Choi KM, Kim RJ, Gubernikoff G et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-7.
37. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
38. Kwong RY, Schussheim AE, Rekhraj S et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;1047:531-7.
39. Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001;13:367-371.
40. Doherty NE, Fujita N, Caputo GR et al. Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging. Am J Cardiol 1992;69:1223-8.
41. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8.
42. McCrohon JA, Moon JC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
43. Zimmermann O, Grebe O, Merkle N et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 2006;8:162-6.
44. Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005;45:743-8.
45. Assomull RG, Prasad SK, Lyne J et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
46. Nazarian S, Bluemke DA, Lardo AC et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5.
47. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004;90:645-9.
48. Rickers C, Wilke NM, Jerosch-Herold M et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61.
49. Arrive L, Assayag P, Russ G et al. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy. J Comput Assist Tomogr 1994;18:376-82.
50. Kramer CM, Reichek N, Ferrari VA, Theobald T, Dawson J, Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994;90:186-94.
51. Choudhury L, Mahrholdt H, Wagner A et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64.
52. Moon JC, McKenna WJ, McCrohon JA, Elliot PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
53. Teraoka K, Hirano M, Ookubo H et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22:155-61.
54. White RD, Obuchowski NA, Gunawardena S et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. Am J Card Imaging 1996;10:1-13.
55. Sievers B, Moon JC, Pennell DJ. Images in cardiovascular medicine. Magnetic resonance contrast enhancement of iatrogenic septal myocardial infarction in hypertrophic cardiomyopathy. Circulation 2002;105:1018.
56. Van Dockum WG, Ten Cate FJ, Ten Berg JM et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:27-34.
57. Shimada T, Shimada K, Sakane T et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-7.
58. Fattori R, Rocchi G, Celletti F et al. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998; 136:824-30.
59. Anderson LJ, Holden S, Davis B et al. Cardiovascular T2* magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9.
60. Sechtem U, Higgins CB, Sommerhoff BA et al. Magnetic resonance imaging of restrictive cardiomyopathy. Am J Cardiol 1987;59:480-2.
61. Furber A, Pézard P, Le Jeune JJ, Geslin P, Tadei A, Jallet P. Radionuclide angiography and magnetic resonance imaging: complementary non invasive methods in the diagnosis of constrictive pericarditis. Eur J Nucl Med 1995;22: 1292-8.
62. Anderson LJ, Wonke B, Prescott E et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia. Lancet 2002;360:516-20.
63. Westwood M, Anderson LJ, Firmin DN et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:616-20.
64. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
65. Davies RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R. Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 2002;21:674-9.
66. Abdel-Aty H, Boye P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22.
67. Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
68. Laissy JP, Messin B, Varenne O et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002;122:1638-48.
69. De Cobelli F, Pieroni M, Esposito A et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 2006;47:1649-54.
70. Wagner A, Schulz-MengerJ, Dietz R, Friedrich MG. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. Magma 2003;16:17-20.
71. Mahrholdt H, Wagner A, Holly TA et al. Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging. Circulation 2002;106:2322-7.
72. Vignaux O, Dhote R, Duboc D et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122:1895-901.
73. Dupuis JM, Victor J, Furber A, Pezard P, Le Jeune JJ, Tadei A. Intérêt de l'imagerie par résonance magnétique dans la sarcoïdose cardiaque. A propos d'une observation. Arch Mal Coeur 1994;87:105-10.
74. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. Am J Roentgenol 2005;184:249-54.
75. Smedema JP, Snoep G, van Kroonenburgh MP et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-90.
76. Smedema JP, van Paassen P, van Kroonenburgh MJ, Snoep G, Crijns HJ, lervaert JW. Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 2004;22:S75-8 (Suppl 36).
77. Allanore Y, Vignaux O, Arnaud L et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 2006;65:249-52.
78. Rochitte CE, Oliveira PF, Joalbo M et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas disease. J Am Coll Cardiol 2005;46:1553-8.
79. Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 2004;19:848-58.
80. Furber A, Victor J, Merheb M et al. La présence d'hypersignaux ventriculaires droits est-elle suffisante pour le diagnostic de dysplasie ventriculaire droite ? Arch Mal Coeur 1996;89:1167-75.
81. Klersy C, Raisaro A, Salerno JA et al. Arrhythmogenic right and left ventricular disease: evaluation by computed tomography and nuclear magnetic resonance imaging. Eur Heart J 1989;10 (suppl D), 33-36.
82. Casolo GC, Poggesi L, Boddi M et al. ECG-gated magnetic resonance imaging in right ventricular dysplasia. Am Heart J 1987;113:1245-8.
83. Tandri H, Calkins H, Nasir K et al. MR imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2003;14:476-83.
84. Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 1996;76:467-70.
85. Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular dysplasia: MR imaging vs. angiography. Am J Roentgenol 1993;161:549-55.
86. Molinari G, Sardanelli F, Gaita F et al. Right ventricular dysplasia as a generalized cardiomyopathy? Findings on magnetic resonance imaging. Eur Heart J 1995;16:1619-24.
87. Desai MY, Gupta S, Bomma C et al. The apparent inversion time for optimal delayed enhancement magnetic resonance imaging differs between the right and left ventricles. J Cardiovasc Magn Reson 2005;7: 475-9.
88. Tandri H, Saranathan M, Rodriguez ER et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45: 98-103.
89. Kayser HW, de Roos A, Schalij MJ et al. Usefulness of magnetic resonance imaging in diagnosis of arrhythmogenic right ventricular dysplasia and agreement with electrocardiographic criteria. Am J cardiol 2003;91:365-7.
90. Kato R, Lickfett L, Meininger G et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation. Circulation 2003;107:2004-10.
91. Yan AT, Shayne AJ, Brown KA et al. Characterization of the periinfarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9.
92. Schmidt A, Azevedo CF, Cheng A et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14.
93. White JA, Yee R, Yuan X et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60.
94. Ypenburg C, Roes SD, Bleeker GB et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J cardiol 2007;99:657-60.
95. O Vignaux Imagerie Cardiaque Scanner et IRM. Valves et flux. D. Didier : 220. Masson Paris ; mai 2005.
96. Wang ZJ, Reddy GP, Gotway MB, Yeh BM, Higgins CB. Cardiovascular shunts: MR imaging evaluation. Radiographics 2003:S181-94.
97. Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI. Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardiovasc Magn Reson 2001;3:11-9.
98. Vahanian A, Baumgartner H, Bax J et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 2007 28:230-68.
99. John AS, Dill T, Brandt RR et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol 2003;42:519-26.
100. Reant P, Lederlin M, Lafitte S. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation . Eur J Radiol 2006;59:276-83.
101. Malyar NM, Schlosser T, Barkhausen J et al. Assessment of Aortic Valve Area in Aortic Stenosis Using Cardiac Magnetic Resonance Tomography: Comparison with Echocardiography. Cardiology 2007;109:126-34.
102. Kupfahl C, Honold M, Meinhardt G et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart 2004;90:893-901.
103. Friedrich M, Schulz-Menger J, Dietz R. Magnetic resonance to assess the aortic valve area in aortic stenosis . J Am Coll Cardiol 2004;43:2148.
104. Caruthers SD, Lin SJ, Brown P, Watkins MP, Williams TA, Lehr KA, Wickline SA. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation 2003;108:2236-43.
105. Tanaka K, Makaryus AN, Wolff SD. Correlation of Aortic Valve Area Obtained by the Velocity-Encoded Phase Contrast Continuity Method to Direct Planimetry using Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 2007;9:799-805.
106. Djavidani B, Debl K, Lenhart M et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol 2005;45:2048-53.
107. Lin SJ, Brown PA, Watkins MP et al. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. J Am Coll Cardiol 2004;44:133-7.
108. Wagner S, Auffermann W, Buser P et al. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance images. Am Heart J 1989;118:760-7.
109. Pflugfelder PW, Landzberg JS, Cassidy MM et al. Comparison of cine MR imaging with Doppler echocardiography for the evaluation of aortic regurgitation. Am J Roentgenol 1989;152:729-35.
110. Sechtem U, Pflugfelder PW, Cassidy MM et al. Mitral or aortic regurgitation: quantification of regurgitant volumes with cine MR imaging. Radiology 1988;167:425-30.
111. Chatzimavroudis GP, Oshinski JN, Franch RH, Pettigrew RI, Walker PG, Yoganathan AP. Quantification of the aortic regurgitant volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. J Heart Valve Dis 1998;7:94-101.
112. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992;185:235-40.
113. Gelfand EV, Hughes S, Hauser TH et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 2006;8:503-7.
114. Aurigemma G, Reichek N, Schiebler M, Axel L. Evaluation of mitral regurgitation by cine magnetic resonance imaging. Am J Cardiol 1990;66:621-5.
115. Higgins CB, Wagner S, Kondo C, Suzuki J, Caputo GR. Evaluation of valvular heart disease with cine gradient echo magnetic resonance imaging. Circulation 1991;84:198-207 (Suppl).
116. Stork A, Franzen O, Ruschewski H et al. Assessment of functional anatomy of the mitral valve in patients with mitral regurgitation with cine magnetic resonance imaging: comparison with transesophageal echocardiography and surgical results. Eur Radiol 2007;17:3189-98.
117. Kon MW, Myerson SG, Moat NE, Pennell DJ. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 2004;13:600-7.
118. Fujita N, Chazouilleres AF, Hartiala JJ et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1994;23: 959-60.
119. Kaji S, Nasu M, Yamamuro A et al. Annular geometry in patients with chronic ischemic mitral regurgitation: three-dimensional magnetic resonance imaging study. Circulation 2005;112:I409-14 (Suppl).
120. D'Ancona G, Mamone G, Marrone G et al. Ischemic mitral valve regurgitation: the new challenge for magnetic resonance imaging. Eur J Cardiothorac Surg 2007;32:475-80.
121. Shellock FG. Prosthetic heart valves and annuloplasty rings: assessment of magnetic field interactions, heating, and artifacts at 1.5 Tesla. J Cardiovasc Magn Reson 2001;3:317-24.
122. Kozerke S, Hasenkam JM, Nygaard H, Paulsen PK, Pedersen EM, Boesiger P. Heart motion-adapted MR velocity mapping of blood velocity distribution downstream of aortic valve prostheses: initial experience. Radiology 2001;218:548-55.
123. Schwartz DR, Belkin RN, Pucillo AL et al. Aneurysm of the mitral-aortic intervalvular fibrosa complicating infective endocarditis: preoperative characterization by two-dimensional and color flow Doppler echocardiography, magnetic resonance imaging, and cineangiography. Am Heart J 1990;119:196-9.
124. Sievers B, Brandts B, Franken U, Trappe HJ. Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis. Am J Med 2003;115:681-2.
125. Saghir S, Ivey TD, Kereiakes DJ, Mazur W. Anterior mitral valve leaflet aneurysm due to infective endocarditis detected by cardiac magnetic resonance imaging. Rev Cardiovasc Med 2006;7:157-9.
126. Schreiber K, Zuern CS, Gawaz M. Loeffler endocarditis: findings on magnetic resonance imaging. Heart 2007;93:354.
127. Harris KM, Ang E, Lesser JR, Sonnesyn SW. Cardiac magnetic resonance imaging for detection of an abscess associated with prosthetic valve endocarditis: a case report. Heart Surg Forum 2007;10:E186-7.
128. Vilacosta I, Gomez J. Complementary role of MRI in infectious endocarditis. Echocardiography 1995;12:673-6.
129. Furber A, Geslin P, Le Jeune JJ et al. Valeur de l'IRM avec injection de gadolinium dans le diagnostic d'abcès de l'anneau mitral : à propos d'un cas. Arch Mal Coeur Vaiss 1997;90:399-404.
130. Mulvagh SL, Rokey R, Vick GW 3rd, Johnston DL. Usefulness of nuclear magnetic resonance imaging for evaluation of pericardial effusions, and comparison with two-dimensional echocardiography. Am J Cardiol 1989;64:1002-9.
131. Sechtem U, Tscholakoff D, Higgins CB. MRI of the abnormal pericardium. AJR Am J Roentgenol 1986;147:245-52.
132. Didier D. Imagerie du péricarde et des valves : apport du scanner multicoupe et de l'IRM. J Radiol 2004;85:1854-77.
133. Glockner JF. Imaging of pericardial disease. Magn Reson Imaging Clin N Am 2003;11:149-62.
134. Kim JS, Kim HH, Yoon Y. Imaging of pericardial diseases. Clin Radiol 2007;62:626-31.
135. Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol 2006;16:569-74.
136. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992;182:369-73.
137. Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilemma. Heart 2001;86:619-23.
138. Giorgi B, Mollet NRA, Dymarkowski S, Rademakers FE, Bogaert J. Clinically Suspected Constrictive Pericarditis: MR Imaging Assessment of Ventricular Septal Motion and Configuration in Patients and Healthy Subjects. Radiology 2003;228:417-24.
139. Luna A, Ribes R, Caro P, Vida J, Erasmus JJ. Evaluation of cardiac tumors with magnetic resonance imaging. Eur Radiol 2005;15:1446-55.
140. Hoffmann U , Globits S, Schima W, Loewe C, Puig S, Oberhuber G, Frank H, Usefulness of Magnetic Resonance Imaging of Cardiac and Paracardiac Masses Am J Cardiol 2003;92:890-5.
141. Freedberg RS, Kronzon I, Rumancik WM et al. The contribution of magnetic resonance imaging to the evaluation of intracardiac tumors diagnosed by echocardiography. Circulation 1988;77:96-103.
142. Lund JT, Ehman RL, Julsrud PR et al. Cardiac masses: assessment by MR imaging. Am J Roentgenol 1989;152:469-73.
143. Semelka RC, Shoenut JP, Wilson ME et al. Cardiac masses: signal intensity features on spin-echo, gradient-echo, gadolinium-enhanced spin-echo, and TurboFlash images. J Magn Reson Imaging 1992;2:415-20.
144. Cesare ED, Giordano AV, Cerone G et al. Comparative evaluation of TEE, conventional MRI and contrast-enhanced 3D breath-hold MRA in the post-operative follow-up of dissecting aneurysms. Int J Card Imaging 2000;16:135-47.
145. Deutsch HJ, Sechtem U, Meyer H et al. Chronic aortic dissection: comparison of MR imaging and transesophageal echocardiophy. Radiology 1994;192:645-50.
146. Nienaber CA, Von Kodolitsch Y, Nicolas V et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9.
147. Sommer T, Fehske W, Holzknecht N et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiophy, and MR imaging. Radiology 1996;199:347-52.
148. Murray JG, Manisali M, Falmm DG et al. Intramural hematoma of the thoracic aorta: MR image findings and their prognostic implications. Radiology 1997;204:349-55.
149. Oudkerk M, Van Beek EJ, Wielopolski P et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002;359:1643-7.
150. Goyen M, Laub G, Ladd Me et al. Dynamic 3D MR angiography of the pulmonary arteries in under four seconds. J Magn Reson Imaging 2001;13:372-7.
151. Crochet D, Lefèvre M, Grossetête R et al. Evaluation comparée de l'IRM, de ĺchocardiographie et du cathé térisme pour le diagnostic des cardiopathies congénitales. Arch Mal Coeur 1990;83:681-3.
152. Taylor AM, Stables RH, Poole-Wilson PA et al. Definitive clinical assessment of atrial septal defect by magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:43-7.
153. Didier D, Higgins CB. Identification and localization of ventricular septal defect by gated magnetic resonance imaging. Am J Cardiol 1986;57:1363-8.
154. Hundley WG, Li HF, Lange RA et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oxymetric and indicator dilution techniques. Circulation 1995;91:2955-60.
155. Choi YH, Park JH, Choe YH et al. MR imaging of Ebstein's anomaly of the tricuspid valve. Am J Roentgenol 1994;163:539-43.
156. Mohiaddin RH, Kilner PJ, Rees S et al. Magnetic resonance volume flow and jet velocity mapping in aortic coarctation. J Am Coll Cardiol 1993;22:1515-21.
157. Steffens JC, Bourne MW, Sakuma H et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation 1994;90:937-43.
158. Nielsen JC, Powell AJ, Gauvreau K et al. Magnetic resonance imaging predictors of coarctation severity. Circulation 2005;111:622-8.
159. Kersting-Sommerhoff BA, Sechtem UP, Fisher MR et al. MR imaging of congenital anomalies of the aortic arch. Am J Roentgenol 1987;149:9-13.
160. Gomes AS, Lois JF, Williams RG. Pulmonary arteries : MR imaging in patients with congenital obstruction of the right ventricular outflow tract. Radiology 1990;174:51-7.
161. Sridharan S, Derrick G, Deanfield J et al. Assessment of differential branch pulmonary blood flow : a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging. Heart 2006;92:963-8.
162. Geva T, Greil GF, Marshall AC et al. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia : comparison with X-ray angiography. Circulation 2002:106;473-8.
163. Greil GF, Powell AJ, Gildein HP et al. Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 2002;39:335-41.
164. Prasad SK, Soukias N, Hornung T et al. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation 2004;109:207-14.
165. Kersting-Sommerhoff B, Diethelm L, Teitel DF et al. Magnetic resonance imaging of congenital heart disease : sensitivity and specificity using receiver operating characteristic curve analysis. Am Heart J 1989;118:155-61.
166. Gorincour G, Lapierre C, Miro J et al. The role of cardiac magnetic resonance in the diagnosis of anomalous pulmonary venous return with subsequent Amplatzer device treatment. J Cardiovasc Magn Reson 2006;8:499-502.
167. Duerinckx AJ, Troutman B, Allada V et al. Coronary MR angiography in Kawasaki disease. Am J Roentgenol 1997;168:114-6.
168. Greil GF, Stuber M, Botnar RM et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002;105:908-11.
169. Post JC, Van Rossum AC, Bronzwaer JG et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 1995;92:3163-71.
170. Bunce NH, Lorenz CH, Keegan J et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology 2003;227:201-8.
171. Salehian O, Schwerzmann M, Merchant N et al. Assessment of systemic right ventricular function in patients with transposition of the great arteries using the myocardial performance index. Comparison with cardiac magnetic resonance imaging. Circulation 2004;110:3229-33.
172. Geva T, Vick GW, Wendt RE et al. Role of spin echo and cine magnetic resonance imaging in presurgical planning of heterotaxy syndrome. Comparison with echocardiography and catheterization. Circulation 1994;90:348-56.
173. Mirowitz SA, Gutierrez FR, Canter CE et al. Tetralogy of Fallot: MR findings. Radiology 1989;171:207-12.
174. Kersting-Sommerhoff B, Seelos KC, Hardy C et al. Evaluation of surgical procedures for cyanotic congenital heart disease by using MR imaging. Am J Roentgenol 1990;155:259-66.
175. Razavi R, Hill DL, Keevil SF et al. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 2003;362:1877-82.
176. Festa P, Ait Ali L, Bernabei M et al. The role of magnetic resonance imaging in the evaluation of the functionally single ventricle before and after conversion to the Fontan circulation. Cardiol Young 2005;15:51-6.
177. Mayo JR, Roberson D, Sommerhoff B et al. MR imaging of double outlet right ventricle. J Comput Assist Tomogr 1990;14:336-9.
178. Araoz PA, Reddy GP, Thomson PD et al. Images in cardiovascular medicine. Magnetic resonance angiography of criss-cross heart. Circulation 2002;105:537-8.
179. Yoo SJ, Kim YM, Choe YH. Magnetic resonance imaging of complex congenital heart disease. Int J Card Imaging 1999;15:151-60.
180. Petersen SE, Selvanayagam JB, Wiesmann F et al. Left ventricular non-compaction. J Am Coll Cardiol 2005;46:101-5.
181. Bogaert J, Kuzo R, Dymarkowski S et al. Follow-up of patients with previous treatment for coarctation of the thoracic aorta: comparison between contrast-enhanced MR angiography and fast spin-echo MR imaging. Eur Radiol 2000;10:1847-54.
182. Oosterhof T, Mulder BJ, Vliegen HW et al. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot : a review. Am Heart J 2006;151:265-72.
183. Roest AA, Helbing WA, Kunz P et al. Exercise MR imaging in the assessment of pulmonary regurgitation and biventricular function in patients after tetralogy of Fallot repair. Radiology 2002;223:204-11.
184. Schievano S, Coats L, Migliavacca F et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease : implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson 2007;9:687-95.
185. Greenberg SB, Crisci LK, Koenig P et al. Magnetic resonance imaging compared with echocardiography in the evaluation of pulmonary artery abnormalities in children with tetralogy of Fallot following palliative and corrective surgery. Pediatr Radiol 1997;27:932-5.
186. Niezen RA, Helbing WA, van der Wall EE et al. Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy de Fallot. Radiology 1996;201:135-40.
187. Ordovas KG, Tan C, Reddy GP et al. Disparity between ratios of diameters and blood flows in central pulmonary arteries in postoperative congenital heart disease using MRI. J Magn Reson Imaging 2007;25:721-6.
188. Rebergen SA, Ottenkamp J, Doornbos J et al. Postoperative pulmonary flow dynamics after Fontan surgery : assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol 1993;21:123-31.
189. Lilje C, Habermann CR, Weil J. Magnetic resonance imaging follow up of total cavopulmonary connection. Heart 2005;91:395.
190. Fogel MA, Weinberg PM, Chin AJ et al. Late ventricular geometry and performance changes of functional single ventricle throughout staged Fontan reconstruction assessed by magnetic resonance imaging. J Am Coll Cardiol 1996; 28:212-21.
191. Kondo C, Hardy C, Higgins SS et al. Nuclear magnetic resonance imaging of the palliative operation for hypoplastic left heart syndrome. J Am Coll Cardiol 1991;18:817-23.
192. Chung KJ, Simpson IA, Glass RF et al. Cine magnetic resonance imaging after surgical repair in patients with transposition of the great arteries. Circulation 1988;77:104-9.
193. Holmqvist C, Oskarsson G, Stahlberg F et al. Functional evaluation of extracardiac ventriculo-pulmonary conduits and of the right ventricle with magnetic resonance imaging and velocity mapping. Am J Cardiol 1999;83:926-32.